Mammalian target of rapamycin as a therapeutic target in leukemia.

@article{Giles2005MammalianTO,
  title={Mammalian target of rapamycin as a therapeutic target in leukemia.},
  author={Francis J Giles and Maher Albitar},
  journal={Current molecular medicine},
  year={2005},
  volume={5 7},
  pages={653-61}
}
Reflecting its critical role in integrating cell growth and division with the cellular nutritional environment, the mammalian target of rapamycin *(mTOR) is a highly conserved downstream effector of the phosphatidylinositol 3-kinase (PI3K)/Akt (protein kinase B) signaling pathway. mTOR activates both the 40S ribosomal protein S6 kinase (p70s6k) and the eukaryotic initiation factor 4E-binding protein-1. As a consequence of inhibiting its downstream messengers, mTOR inhibitors prevent cyclin… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

Similar Papers

Loading similar papers…